ArticleMedicine2025
Causal effects of gut microbiota on IgG levels after Helicobacter pylori (H pylori) infection: Insights from genome-wide Mendelian randomization.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Alternative splicing-based therapeutics for neurodegenerative diseases: a dual-database bibliometric and NLP-driven analysis (2000-2025).Frontiers in medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gut microbiota has been reported to influence immune responses and various diseases. However, the causal relationship between specific bacterial taxa and IgG levels following H pylori infection remains unclear. We employed a two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) summary statistics to evaluate the causal effects of gut microbiota composition on IgG levels post-H pylori infection. Robustness was assessed through sensitivity analyses, including MR-Egger, weighted median, and MR-PRESSO tests. Additionally, functional enrichment analysis of significant genes was performed to explore potential biological pathways. Our MR analysis identified 11 microbial taxa significantly associated with IgG levels. Six gut microbial taxa, including Akkermansia and Ruminococcaceae UCG002, exhibit a negative causal association with IgG level changes, exerting beneficial effects. Conversely, 5 taxa such as Parabacteroides and Dialister display a significant positive causal relationship with IgG level alterations, potentially inducing excessive activation or suppression of the immune system and leading to detrimental consequences. Sensitivity analyses confirmed the robustness of these findings with no evidence of pleiotropy or heterogeneity. Functional enrichment analysis highlighted pathways linked to immune regulation, neurotransmitter signaling, and inflammatory responses. This study elucidates the causal relationships between gut microbiota and IgG levels after H pylori infection, offering insights into microbiota-mediated immune modulation and potential targets for therapeutic intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.